Q1 Productions' Pharmaceutical Competitive Intelligence & New Product Planning Conference this October will focus on providing executives with a forum for frank discussion & debate surrounding CI & new product planning, which will ultimately assist corporations in making the best decisions regarding product introductions. As we have seen, market increases in competitiveness & profit margins continue to retract, and it is important for companies to truly appreciate & invest in new product planning initiatives.

Today's executives must have a thorough knowledge of how to collect great volumes of data & best manipulate information into an understandable format for upper-level management. Conference presentations will highlight examples & best practices of organizations that have achieved success in these matters.

Market forecasting & its unpredictable nature also proves to be a focal point for the industry. Accurately & realistically estimating the market opportunity for a new product is a key consideration in decision making regarding its planning. Understanding the level of sales & integration a product will achieve within the market is absolutely essential & cannot be accurately determined without a thorough knowledge of existing products on the market & competitive products to be released.

As organizations consider delving into new therapeutic areas, the challenges in new product planning & CI become even more difficult. Building a base of information from the ground up is an excruciating process, & many companies look to partner with outside consultants that have this information already established. Understanding how to accurately evaluate potential partners & how to determine the relevance of their data is an important piece of the practice.

Presenters will cover a wide variety of topics along with bringing a wide spectrum of experiences. Hearing from companies both small & large will enable attendees to experience a well-rounded program.

For more information visit: 

q1productions/RXCI

When: October 3 - 4, 2011 



Where: Boston, MA

Who: This conference is ideal for senior-level executives involved in from the Pharmaceutical industry interested in discussing their challenges and insights in competitive intelligence and new product planning.

Presenting organizations include: Arizona Blue Cross Blue Shield, Astellas Pharma, Biogen Idec, Daiichi Sankyo, Digimind Inc., Endo Pharmaceuticals, GE Healthcare, Genzyme, Mannkind Corporation, Merz Pharmaceuticals, LLC, Pfizer, Pharmavoxx, Sanofi-Aventis, Sterne, Kessler, Goldstein & Fox PLLC, Upsher-Smith Laboratories & Vertex Pharmaceuticals Incorporated 


About the Organizer 


Q1 Productions has over 25 years of combined event production experience, with previous roles in international Sales Management, Productions and Operations. Focusing on new or pending legislative issues, enhanced business processes or technologies that will drive efficiency and customer service, our conference programs provide solutions to the urgent needs of our attendees.